Accellent to refinance its existing senior secured credit facilities

NewsGuard 100/100 Score

Accellent Inc. (“Accellent” or “the Company”) announced today that it has adopted a plan to refinance (the "Refinancing") its existing senior secured credit facilities and replace them with indebtedness that has longer-dated maturities. The plan, which has been unanimously approved by the Company's Board of Directors, would strengthen the Company’s capital structure by extending nearer term maturities such that the Company has no maturities until November 2013.

“This transaction accomplishes a key objective in recapitalizing Accellent for the long term”

Pursuant to the plan, the Company would enter into a new asset-based revolving credit facility with undrawn commitments thereunder of up to $75 million maturing in 2015 (the "ABL Revolver"), which will become effective upon completion of the Refinancing and would issue approximately $400 million in aggregate principal amount of senior secured notes due 2017 (the "Notes"). Proceeds from the Notes will be used to re-pay the Company’s existing senior secured credit facility.

"This transaction accomplishes a key objective in recapitalizing Accellent for the long term," said Kenneth W. Freeman, Executive Chairman and acting Chief Executive Officer of Accellent.

Upon completion of the transactions, the ABL Revolver would be secured by first-priority liens on all accounts receivable, inventory, cash, related general intangibles and instruments and proceeds of the foregoing (the "ABL Collateral") and by second-priority liens on all the other assets of the Company and the guarantors of the ABL Revolver. The Notes would be secured by first-priority liens on all the assets other than the ABL Collateral owned by the Company and the guarantors of the Notes and by second-priority liens on the ABL Collateral

Source:

Accellent

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.